Share Price:
Print
Alert

Partners

Why collaborate with Hikma?

  • Strong market position and established infrastructure necessary for continued growth across the MENA region
  • Reputation for high-quality products, FDA-approved facilities and a long and successful track record with global licensing partners
  • Strong brand recognition and experienced sales and marketing teams throughout MENA with strong customer loyalty
  • Local manufacturing facilities investment in local market registration and pricing advantages
  • Excellent knowledge of registration processes and connections with local health authorities
  • Existing network of distribution channels

Currently Hikma collaborates with:


Astellas
Japan

 

Synthon
Netherlands

 

Genepharm
Greece

 

Pharmathen
Greece

 

FAES
Spain

 

Skyepharma
Switzerland

 

Novintethical
Switzerland

 

Vifor Pharma
Switzerland

 


Aptalis Pharma
US

 

Takeda
Japan

 

Zydus Cadila
India

 

Dong-A
Korea

 

Teikoku
US

 

YOU MAY ALSO BE INTERESTED IN...

Our businesses

Providing patients with high-quality medicines through three core business segments.

News and press releases

Click here for the latest updates on Hikma